US 12,102,454 B2
Analysis of glucose median, variability, and hypoglycemia risk for therapy guidance
Timothy C. Dunn, San Francisco, CA (US); Kenneth J. Doniger, Menlo Park, CA (US); Glenn Berman, Alameda, CA (US); Gary A. Hayter, Oakland, CA (US); Erwin S. Budiman, Fremont, CA (US); Daniel M. Bernstein, El Granada, CA (US); and Nathan Crouther, San Francisco, CA (US)
Assigned to Abbott Diabetes Care Inc., Alameda, CA (US)
Filed by Abbott Diabetes Care Inc., Alameda, CA (US)
Filed on May 11, 2022, as Appl. No. 17/742,088.
Application 17/742,088 is a continuation of application No. 17/122,990, filed on Dec. 15, 2020, granted, now 11,331,051.
Application 17/122,990 is a continuation of application No. 16/459,203, filed on Jul. 1, 2019.
Application 16/459,203 is a continuation of application No. 14/145,554, filed on Dec. 31, 2013, granted, now 10,383,580, issued on Aug. 20, 2019.
Application 14/145,554 is a continuation in part of application No. 13/732,184, filed on Dec. 31, 2012, granted, now 9,351,670, issued on May 31, 2016.
Prior Publication US 2022/0280122 A1, Sep. 8, 2022
Int. Cl. A61B 5/145 (2006.01); A61B 5/00 (2006.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01)
CPC A61B 5/7275 (2013.01) [A61B 5/14532 (2013.01); G16H 50/20 (2018.01); A61B 5/743 (2013.01); G16H 50/30 (2018.01)] 14 Claims
OG exemplary drawing
 
1. A system for managing diabetes during pregnancy, the system comprising:
a continuous glucose monitor comprising a sensor configured to be positioned in interstitial tissue of a patient, such that the continuous glucose monitor is configured to monitor glucose levels of the patient; and
a display device in wireless communication with the continuous glucose monitor to receive the monitored glucose levels, wherein the display device comprises:
an input device,
a display,
a non-volatile, non-transitory memory storing a glucose data processing program, and
a processor coupled with the non-volatile, non-transitory memory, and configured to execute the glucose data processing program to cause the processor to:
adjust a threshold for determining a glycemic risk level from a first setting to a second setting that is different than the first setting based on a pregnant condition of the patient, wherein the threshold comprises a fraction of a period of time in which glucose levels are below a predetermined low glucose level, wherein the first setting comprises a first fraction of the period of time in which glucose levels are below the predetermined low glucose level and the second setting comprises a second fraction of the period of time in which glucose levels are below the predetermined low glucose level, and wherein the second fraction is greater than the first fraction,
determine a glucose metric for one or more periods of time based on the received monitored glucose levels,
determine the glycemic risk level for the one or more periods of time based on a comparison of the determined glucose metric to the threshold, and
determine a treatment recommendation based at least in part on the glycemic risk level, wherein the treatment recommendation comprises a modification to self-care behavior.